Newbridge Financial Services Group’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
Other funds holding ARKG
Newbridge Financial Services Group's ARKG Position: Q1 2025 in Review
Newbridge Financial Services Group sold out of ARK Genomic Revolution ETF (ARKG) in Q1 2025, closing a stake of 77 shares — an estimated $1.81K sold.
Newbridge Financial Services Group first reported a position in ARKG in Q4 2020 and held it in 17 quarters. The position peaked at $85K in Q2 2021. 214 funds tracked by Wall St. Rank hold ARKG as of Q1 2025.
- Newbridge Financial Services Group reported no remaining ARK Genomic Revolution ETF position as of Q1 2025 after selling out during the quarter.
- Newbridge Financial Services Group sold 77 ARK Genomic Revolution ETF shares in Q1 2025, an estimated $1.81K.
- Newbridge Financial Services Group first reported a position in ARK Genomic Revolution ETF in Q4 2020 and held it in 17 quarters.
- Newbridge Financial Services Group's ARK Genomic Revolution ETF position peaked at $85K in Q2 2021.
- 214 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2025.
Based on Newbridge Financial Services Group's 13F filing for Q1 2025, filed 15 May 2025.